Phillip Frost, M.D. 13D and 13G filings for Cocrystal Pharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-06-09 5:44 pm Purchase | 2021-06-09 | 13D | Cocrystal Pharma, Inc. COCP | Phillip Frost, M.D. | 310,526 3.800% | 310,526 (New Position) | Filing |